Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations.
Autor: | Kossoff EH; Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States of America; Department of Neurology, Johns Hopkins University, Baltimore, MD, United States of America. Electronic address: ekossoff@jhmi.edu., Turner Z; Division of Nutrition, Department of Pediatrics, Johns Hopkins Hospital, Baltimore, MD, United States of America., Adams J; Division of Nutrition, Department of Pediatrics, Johns Hopkins Hospital, Baltimore, MD, United States of America., Bessone SK; Institute for Brain Protection Sciences, Johns Hopkins University School of Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States of America., Avallone J; Department of Nutritional Services, Johns Hopkins University School of Medicine, United States of America., McDonald TJW; Department of Neurology, Johns Hopkins University, Baltimore, MD, United States of America., Diaz-Arias L; Department of Neurology, Johns Hopkins University, Baltimore, MD, United States of America., Barron BJ; Institute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Vizthum D; Institute for Clinical and Translational Research, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Cervenka MC; Department of Neurology, Johns Hopkins University, Baltimore, MD, United States of America. |
---|---|
Jazyk: | angličtina |
Zdroj: | Epilepsy & behavior : E&B [Epilepsy Behav] 2020 Oct; Vol. 111, pp. 107181. Date of Electronic Publication: 2020 May 25. |
DOI: | 10.1016/j.yebeh.2020.107181 |
Abstrakt: | The current coronavirus-19 pandemic has changed dramatically how neurologists care for children and adults with epilepsy. Stay-at-home orders and resistance to hospitalizations by patients have led epileptologists to engage in telemedicine and reevaluate how to provide elective services. Ketogenic diet therapy is often started in the hospital, with families educated in hospital-based classes, but this is difficult to do in this current pandemic. At our two academic centers, both our pediatric and adult epilepsy diet centers have had to quickly consider alternative methods to both start and maintain ketogenic diet therapy. This paper provides several examples of how ketogenic diet therapy can be provided to patients in unique ways, along with recommendations from other experts and patients, learned over the past few months. Competing Interests: Declaration of competing interest Dr. Kossoff is on the scientific advisory board of Nutricia, Bloom Science, and Atkins Nutritionals and is a consultant to Vitaflo and Greenwich. Ms. Turner and Bessone are consultants to Nutricia. Dr. McDonald has received speaking honoraria from Nutricia. Ms. Barron has received support from The Johns Hopkins Institute for Clinical and Translational Research (ICTR), funded in part by NIH grants (UL1 TR 001079 NCATS), NIH Roadmap for Medical Research, Nutricia, Vitaflo, and The Carson Harris Foundation. Dr. Cervenka has received support from the Epilepsy Foundation, the School of Medicine, Johns Hopkins University Clinician Scientist Award, Nutricia, Vitaflo, the Carson Harris Foundation, Owens Family Foundation, Elaine Freeman and Johns Hopkins University Department of Neurosurgery, NIH (NINDS R01NS075020), and Army Research Laboratory. None of the other authors have any financial disclosures. (Copyright © 2020 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |